Team Health downgraded to Buy from Conviction Buy at Goldman Goldman removed Team Health from the Conviction Buy List based on valuation and higher Street estimates. Shares remain Buy rated with an increased price target of $59 from $56.
News For TMH From The Last 14 Days
Check below for free stories on TMH the last two weeks.
TeamHealth names Miles Snowden as Chief Medical Officer TeamHealth Holdings (TMH) announced the appointment of Miles Snowden, M.D., MPH, as the company's Chief Medical Officer effective September 15. Dr. Snowden is replacing Gar LaSalle, M.D., who retired from this position earlier this year. Snowden most recently served as Chief Medical Officer for Optum, the health services division of UnitedHealth Group (UNH).